The genetics of multiple sclerosis. A review.

[1]  G. McDonnell,et al.  Major histocompatibility complex class II alleles and the course and outcome of MS. , 1999, Neurology.

[2]  H. Alder,et al.  Large scale screening of the mitochondrial DNA reveals no pathogenic mutations but a haplotype associated with multiple sclerosis in Caucasians , 1999, Acta neurologica Scandinavica.

[3]  Susceptibility to multiple sclerosis and the immunoglobulin heavy chain gene cluster , 1998, Annals of neurology.

[4]  A. Goris,et al.  Interferon‐γ gene polymorphism–associated risk for multiple sclerosis in sardinia , 1998, Annals of neurology.

[5]  B. Kálmán,et al.  Is the mitochondrial DNA involved in determining susceptibility to multiple sclerosis? , 1998, Acta neurologica Scandinavica.

[6]  P. Goodfellow,et al.  The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. , 1998, Brain : a journal of neurology.

[7]  M. Clanet,et al.  A systematic study of oligodendrocyte growth factors as candidates for genetic susceptibility to MS , 1998, Neurology.

[8]  D. Schaid,et al.  Major histocompatibility complex class II alleles and the course and outcome of MS , 1998, Neurology.

[9]  J. Haines,et al.  Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. , 1998, Human molecular genetics.

[10]  K. Selmaj,et al.  Multiple sclerosis: The increased frequency of the ICAM‐1 exon 6 gene point mutation genetic type K469 , 1998, Annals of neurology.

[11]  Chun Xu,et al.  Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis , 1998, Journal of Neuroimmunology.

[12]  K. Selmaj,et al.  Multiple sclerosis: the frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha , 1998, Journal of Neuroimmunology.

[13]  D. Paty,et al.  Susceptibility to relapsing-progressive multiple sclerosis is associated with inheritance of genes linked to the variable region of the TcR beta locus: use of affected family-based controls. , 1998, American journal of human genetics.

[14]  J. Hillert,et al.  The myelin basic protein gene in multiple sclerosis: identification of discrete alleles of a 1.3 kb tetranucleotide repeat sequence , 1998, Acta neurologica Scandinavica.

[15]  M. Daly,et al.  Genomewide scan of multiple sclerosis in Finnish multiplex families. , 1997, American journal of human genetics.

[16]  B. Weinshenker,et al.  A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis , 1997, Neurology.

[17]  D. Schaid,et al.  Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis , 1997, Neurology.

[18]  E. Thorsby,et al.  The HLA‐DQ(α1*0102, β1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA‐DR(α1*01, β1*1501) heterodimer , 1997 .

[19]  G. Stewart,et al.  HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patients. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[20]  J. Hillert,et al.  Linkage analysis of HLA class II Genes in Swedish multiplex families with multiple sclerosis , 1997, Neurology.

[21]  H. Przuntek,et al.  Genetic predisposition to multiple sclerosis as revealed by immunoprinting , 1997, Annals of neurology.

[22]  D. Wallace,et al.  Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. , 1997, American journal of human genetics.

[23]  F. Lublin,et al.  Screening for Leber's hereditary optic neuropathy associated mitochondrial DNA mutations in patients with prominent optic neuritis , 1997, Multiple sclerosis.

[24]  S. Hauser,et al.  Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion. , 1996, Human immunology.

[25]  F. Weber,et al.  Gene polymorphism at position −308 of the tumor-necrosis -factor-α (TNF-α) in Multiple Sclerosis and it's influence on the regulation of TNF-α production , 1996, Neuroscience Letters.

[26]  F. Lublin,et al.  Characterization of the mitochondrial DNA in patients with multiple sclerosis , 1996, Journal of the Neurological Sciences.

[27]  G. Rödel,et al.  Mitochondrial DNA mutations in multiple sclerosis patients with severe optic involvement , 1996, Acta neurologica Scandinavica.

[28]  A. Harding,et al.  Sequence of mitochondrial DNA in patients with multiple sclerosis , 1996, Annals of neurology.

[29]  D. Clayton,et al.  Clinical concordance in sibling pairs with multiple sclerosis , 1996, Neurology.

[30]  P. Goodfellow,et al.  A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 , 1996, Nature Genetics.

[31]  J. Haines,et al.  A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex , 1996, Nature Genetics.

[32]  D. Hinds,et al.  A full genome search in multiple sclerosis , 1996, Nature Genetics.

[33]  S. Hauser,et al.  Genetics of Demyelinating Diseases , 1996, Brain pathology.

[34]  N. Risch,et al.  Evidence for genetic basis of multiple sclerosis , 1996, The Lancet.

[35]  A. Goldstein,et al.  DR2/DQwl Inheritance and haplotype sharing in affected siblings from multiple sclergis families , 1996 .

[36]  J. Benedikz,et al.  Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland , 1996, Neurology.

[37]  J. Hillert,et al.  Tumor necrosis factor α-308 alleles in multiple sclerosis and optic neuritis , 1995, Journal of Neuroimmunology.

[38]  F. Pociot,et al.  An evaluation of tumor necrosis factor microsatellite alleles in genetic susceptibility to multiple sclerosis , 1995, Multiple sclerosis.

[39]  C. Polman,et al.  Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis , 1995, The Lancet.

[40]  J. Hillert,et al.  The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. , 1995, Tissue antigens.

[41]  N. Risch,et al.  A genetic basis for familial aggregation in multiple sclerosis , 1995, Nature.

[42]  M. Clanet,et al.  Myelin oligodendrocyte glycoprotein (MOG) gene polymorphisms and multiple sclerosis: no evidence of disease association with MOG , 1995, Journal of Neuroimmunology.

[43]  M. Nishimura,et al.  No association of the 11778 rnitochondrial DNA mutation and multiple sclerosis in Japan , 1995, Neurology.

[44]  G. Stewart,et al.  TAP2 polymorphisms in Australian multiple sclerosis patients , 1995, Journal of Neuroimmunology.

[45]  R. Bell,et al.  The relationship of TAP1 and TAP2 dimorphisms to multiple sclerosis susceptibility , 1995, Journal of Neuroimmunology.

[46]  P. Marynen,et al.  Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DRβ1 chain in multiple sclerosis , 1995, Journal of Neuroimmunology.

[47]  D. Clayton,et al.  Multiple sclerosis and the HLA-D region: linkage and association studies , 1995, Journal of Neuroimmunology.

[48]  T. Rosenberg,et al.  Leber's hereditary optic neuropathy associated with a disorder indistinguishable from multiple sclerosis in a male harbouring the mitochondrial DNA 11778 mutation , 1995, Acta neurologica Scandinavica.

[49]  P. Charmley,et al.  Human T-cell receptor V beta gene polymorphism and multiple sclerosis. , 1995, American journal of human genetics.

[50]  F. Lublin,et al.  Mitochondrial DNA mutations in multiple sclerosis , 1995, Multiple sclerosis.

[51]  M. Sanders,et al.  The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. , 1995, Brain : a journal of neurology.

[52]  B. Weinshenker,et al.  The natural history of multiple sclerosis. , 1995, Neurologic clinics.

[53]  M. Zeviani,et al.  Evidence of Linkage between Susceptibility to Multiple Sclerosis and HLA-Class II Loci in Italian Multiplex Families , 1995, European journal of human genetics : EJHG.

[54]  C. Poser.  The dissemination of multiple sclerosis: A Viking saga? A historical essay , 1994, Annals of neurology.

[55]  F. Hanefeld,et al.  Leber's Hereditary Optic Neuropathy Mitochondrial DNA Mutations in Childhood Multiple Sclerosis* , 1994, Neuropediatrics.

[56]  J. Cassiman,et al.  TAP 1 and TAP 2 transporter gene polymorphisms in multiple sclerosis: No evidence for disease association with TAP , 1994, Journal of Neuroimmunology.

[57]  A. Torroni,et al.  mtDNA and the origin of Caucasians: identification of ancient Caucasian-specific haplogroups, one of which is prone to a recurrent somatic duplication in the D-loop region. , 1994, American journal of human genetics.

[58]  J. Cassiman,et al.  POLYMORPHISM OF THE TUMOUR NECROSIS FACTOR BETA GENE IN MULTIPLE SCLEROSIS AND RHEUMATOID ARTHRITIS , 1994, European journal of immunogenetics.

[59]  A. Sadovnick,et al.  The role of genetic factors in multiple sclerosis susceptibility , 1994, Journal of Neuroimmunology.

[60]  D. Clayton,et al.  No linkage or association between multiple sclerosis and the myelin basic protein gene in affected sibling pairs. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[61]  A. Harding,et al.  Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis , 1994, Annals of neurology.

[62]  F. Vartdal,et al.  No association of multiple sclerosis to alleles at the TAP2 locus. , 1994, Human immunology.

[63]  A. Cambon-Thomsen,et al.  Tumor necrosis factor polymorphisms in multiple sclerosis: No additional association independent of HLA , 1994, Journal of Neuroimmunology.

[64]  J. Hillert,et al.  The HLA-Dw2 haplotype segregates closely with multiple sclerosis in multiplex families , 1994, Journal of Neuroimmunology.

[65]  J. Mcleod,et al.  Epidemiology of multiple sclerosis in Australia: With NSW and SA survey results , 1994, The Medical journal of Australia.

[66]  D. Miller,et al.  The British Isles survey of multiple sclerosis in twins , 1994, Neurology.

[67]  Jan Hillert,et al.  Human leukocyte antigen studies in multiple sclerosis , 1994, Annals of neurology.

[68]  H. Erlich,et al.  Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. , 1994, Human immunology.

[69]  K. Flanigan,et al.  Association of the 11778 mitochondria1 DNA mutation and demyelinating disease , 1993, Neurology.

[70]  J. Kurtzke.  Epidemiologic evidence for multiple sclerosis as an infection , 1993, Clinical Microbiology Reviews.

[71]  J. Kurtzke,et al.  Multiple sclerosis in the Faroe Islands. VI. Studies of HLA markers. , 1993, Tissue antigens.

[72]  G. Francis,et al.  HLA‐DQ polymorphisms do not explain HLA class II associations with multiple sclerosis in two Canadian patient groups , 1993, Neurology.

[73]  P. van Endert,et al.  Antigen processing gene polymorphisms in HLA‐DR2 multiple sclerosis , 1993, Neurology.

[74]  L. Hood,et al.  Susceptibility for multiple sclerosis is determined, in part, by inheritance of a 175-kb region of the TcR Vβ chain locus and HLA class II genes , 1993, Journal of Neuroimmunology.

[75]  Sadovnick Ad.  Familial recurrence risks and inheritance of multiple sclerosis. , 1993 .

[76]  M. Walter,et al.  Immunoglobulin heavy chain variable region polymorphisms and multiple sclerosis susceptibility , 1993, Journal of Neuroimmunology.

[77]  J. Hillert.  Immunoglobulin gamma constant gene region polymorphisms in multiple sclerosis , 1993, Journal of Neuroimmunology.

[78]  D. Paty,et al.  A population‐based study of multiple sclerosis in twins: Update , 1993 .

[79]  Roland Martin,et al.  A functional basis for the association of HLA class II genes adn susceptibility to multiple sclerosis: cellular immune responses to myelin basic protein in a multiplex family , 1993, Journal of Neuroimmunology.

[80]  D. McFarlin,et al.  T-lymphocyte recognition of a portion of myelin basic protein encoded by an exon expressed during myelination , 1993, Journal of Neuroimmunology.

[81]  J. Hillert,et al.  Multiple sclerosis is associated with genes within or close to the HLA‐DR‐DQ subregion on a normal DR15, DQ6, Dw2 haplotype , 1993, Neurology.

[82]  G. Ebers,et al.  MULTIPLE-SCLEROSIS SUSCEPTIBILITY AND THE TUMOR NECROSIS FACTORS , 1993 .

[83]  L. Peltonen,et al.  Reappraisal of HLA in Multiple Sclerosis: Close Linkage in Multiplex Families , 1993, European journal of human genetics : EJHG.

[84]  G. Stewart,et al.  HLA-DPB1 alleles correlate with risk for multiple sclerosis in Caucasoid and Cantonese patients lacking the high-risk DQB1*0602 allele. , 1993, Tissue antigens.

[85]  M. Fernandez,et al.  Restriction fragment length polymorphism analysis of HLA-DR- and DQ-linked alleles in multiple sclerosis in Spain , 1992, Journal of Neuroimmunology.

[86]  G. Grau,et al.  Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis. , 1992, European cytokine network.

[87]  A Sajantila,et al.  Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene , 1992, The Lancet.

[88]  T. Mak,et al.  T cell receptor α chain polymorphisms in multiple sclerosis , 1992, Journal of Neuroimmunology.

[89]  W. Mcdonald,et al.  Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. , 1992, Brain : a journal of neurology.

[90]  G. Francis,et al.  Contribution of a single DQ beta chain residue to multiple sclerosis in French Canadians. , 1992, Human immunology.

[91]  J. Petajan,et al.  Discordance of the T‐cell receptor alpha‐chain gene in familial multiple sclerosis , 1992, Neurology.

[92]  T. Olsson,et al.  Conjugal multiple sclerosis , 1992, Neurology.

[93]  J. Ruidavets,et al.  HLA-DPB1 gene polymorphism and multiple sclerosis: a large case-control study in the southwest of France , 1991, Journal of Neuroimmunology.

[94]  A. Thompson,et al.  Multiple sclerosis and HLA: is the susceptibility gene really HLA-DR or -DQ? , 1991, Human immunology.

[95]  M. Leppert,et al.  Discordance of T‐cell receptor β‐chain genes in familial multiple sclerosis , 1991 .

[96]  G. Füst,et al.  Sclerosis multiplex in gypsies , 1991, Acta neurologica Scandinavica.

[97]  J. Hillert,et al.  HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. , 1991, Tissue antigens.

[98]  J. Hillert,et al.  No association with germline T cell receptor β-chain gene alleles or haplotypes in Swedish patients with multiple sclerosis , 1991, Journal of Neuroimmunology.

[99]  G. Francis,et al.  No association between susceptibility to multiple sclerosis and HLA-DPB1 alleles in the French Canadian population. , 1991, Tissue antigens.

[100]  A. Sadovnick,et al.  Parent‐child concordance in multiple sclerosis , 1991, Annals of neurology.

[101]  C. Brosnan,et al.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.

[102]  D. F. Roberts,et al.  Factor B (BF) allotypes and multiple sclerosis in north-east England. , 1991, Human heredity.

[103]  D. F. Roberts,et al.  Consanguinity and multiple sclerosis in Orkney , 1991, Genetic epidemiology.

[104]  D. McFarlin,et al.  HLA-DR and -DQ allelic sequences in multiple sclerosis patients are identical to those found in the general population. , 1991, Human immunology.

[105]  E. Thorsby,et al.  HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis. , 1991, Human immunology.

[106]  S. Hauser,et al.  Multiple sclerosis sibling pairs , 1990, Neurology.

[107]  G. Dean,et al.  Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[108]  J. Mcleod,et al.  Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? , 1990, Journal of neurology, neurosurgery, and psychiatry.

[109]  D. Middleton,et al.  HLA antigens and multiple sclerosis in northern Ireland , 1990, Irish journal of medical science.

[110]  S. Prusiner,et al.  DNA length polymorphism 5′ to the myelin basic protein gene is associated with multiple sclerosis , 1990, Annals of neurology.

[111]  H. Staunton,et al.  The inheritance of MS susceptibility , 1990, Irish journal of medical science.

[112]  C. Polman,et al.  Magnetic resonance imaging studies in multiple sclerosis twins. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[113]  T. Olsson,et al.  Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[114]  T. Kindt,et al.  A susceptibility locus for multiple sclerosis is linked to the T cell receptor β chain complex , 1989, Cell.

[115]  E. Thorsby,et al.  Patients with multiple sclerosis carry DQB1 genes which encode shared polymorphic amino acid sequences. , 1989, Human immunology.

[116]  G. Francis,et al.  HLA‐DRβ, ‐DQα, and ‐DQβ restriction fragment length polymorphisms in multiple sclerosis , 1989, Journal of neuroscience research.

[117]  H. Weiner,et al.  Extended major histocompatibility complex haplotypes in patients with multiple sclerosis , 1989, Neurology.

[118]  L. Cavalli-Sforza,et al.  T-cell receptor V alpha and C alpha alleles associated with multiple and myasthenia gravis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[119]  L. Hood,et al.  The germline repertoire of T cell receptor β-chain genes in patients with chronic progressive multiple sclerosis , 1989, Journal of Neuroimmunology.

[120]  N. Koch-Henriksen.  An epidemiological study of multiple sclerosis. Familial aggregation social determinants, and exogenic factors. , 1989, Acta neurologica Scandinavica. Supplementum.

[121]  F. Muntoni,et al.  Sardinian multiple sclerosis is associated with HLA‐DR4 , 1988, Neurology.

[122]  J. Kaprio,et al.  Genetic Susceptibility to Multiple Sclerosis: A Co-twin Study of a Nationwide Series , 1988 .

[123]  A. Sadovnick,et al.  The familial nature of multiple sclerosis , 1988, Neurology.

[124]  A. Sadovnick,et al.  Multiple sclerosis: updated risks for relatives. , 1988, American journal of medical genetics.

[125]  C. Huang,et al.  No apparent association between HLA and multiple sclerosis in southern Chinese. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[126]  W. Mcdonald,et al.  HLA genetic determinants in familial MS. A study from the Grampian region of Scotland. , 2008, Tissue antigens.

[127]  R. Swingler,et al.  HLA and multiple sclerosis in south east Wales. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[128]  G. Savettieri,et al.  HLA associations with multiple sclerosis in Sicily and Malta. , 1987, Disease markers.

[129]  W. Mcdonald,et al.  Multiple sclerosis in north-east Scotland. An association with HLA-DQw1. , 1987, Brain : a journal of neurology.

[130]  D. Skegg,et al.  Occurrence of multiple sclerosis in the north and south of New Zealand. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[131]  D. Paty,et al.  A population-based study of multiple sclerosis in twins. , 1986, The New England journal of medicine.

[132]  R. Swingler,et al.  The distribution of multiple sclerosis in the United Kingdom. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[133]  R. Nájera,et al.  Immunogenetic profile of multiple sclerosis in Mexicans. , 1986, Human immunology.

[134]  J. Degos,et al.  Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity. , 1986, The Journal of clinical investigation.

[135]  P. Terasaki,et al.  HLA and Disease Associations , 1985, Springer New York.

[136]  S. Mellgren,et al.  Multiple sclerosis in the two northernmost counties of Norway , 1985, Acta neurologica Scandinavica.

[137]  E. Kinnunen,et al.  Histocompatibility antigens in familial multiple sclerosis in a high-risk area of the disease , 1984, Journal of the Neurological Sciences.

[138]  D. F. Roberts,et al.  Genetic analysis of multiple sclerosis in Shetland. , 1983, Journal of epidemiology and community health.

[139]  G. Ebers.  Genetic factors in multiple sclerosis. , 1983, Neurologic clinics.

[140]  H. Shibasaki,et al.  Prevalence of Multiple Sclerosis and Its North-to-South Gradient in Japan , 1983 .

[141]  D. Paty,et al.  HLA-TYPING IN MULTIPLE SCLEROSIS SIBLING PAIRS , 1982, The Lancet.

[142]  James Wh.  Concordance in twins and recurrence in sibships of multiple sclerosis. , 1982 .

[143]  A. Sadovnick,et al.  The familial nature of multiple sclerosis , 1981, Neurology.

[144]  I. Takács,et al.  The HLA antigen distribution in the Gipsy population in Hungary. , 1981, Tissue antigens.

[145]  J. Goust,et al.  Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis. , 1981, The Journal of clinical investigation.

[146]  F. Sanger,et al.  Sequence and organization of the human mitochondrial genome , 1981, Nature.

[147]  D. McFarlin,et al.  Multiple sclerosis in twins , 1980, Neurology.

[148]  G. Stewart,et al.  Strong linkage disequilibrium between HLA-Dw2 and and BfS in multiple sclerosis and in the normal population. , 2008, Tissue antigens.

[149]  G. Beebe,et al.  Epidemiology of multiple sclerosis in U.S. veterans , 1979, Neurology.

[150]  N. Takahata,et al.  HLA and Japanese MS. , 1978, Tissue antigens.

[151]  J. Brody,et al.  Twin study of multiple sclerosis , 1978, Neurology.

[152]  E. Operskalski,et al.  Multiple sclerosis among Spanish‐surnamed Californians , 1978, Neurology.

[153]  E. Thorsby,et al.  HLA antigens in multiple sclerosis , 1977, Journal of the Neurological Sciences.

[154]  W. Mcdonald,et al.  DIFFERENT B LYMPHOCYTE ALLOANTIGENS ASSOCIATED WITH MULTIPLE SCLEROSIS IN ARABS AND NORTH EUROPEANS , 1977, The Lancet.

[155]  J. Kurtzke.  A REASSESSMENT OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS , 1975, Acta neurologica Scandinavica.

[156]  J. Kurtzke.  A REASSESSMENT OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS , 1975, Acta neurologica Scandinavica.

[157]  J. Kurtzke,et al.  Multiple sclerosis: an epidemic disease in the Faeroes. , 1975, Transactions of the American Neurological Association.

[158]  A. Svejgaard,et al.  Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. , 1973, Lancet.

[159]  G. Dean,et al.  Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa. , 1967, British medical journal.

[160]  R. P. Mackay,et al.  Multiple Sclerosis in Twins and Their Relatives: Final Report , 1966 .

[161]  M. Alter,et al.  Risk of multiple sclerosis related to age at immigration to Israel. , 1966, Archives of neurology.

[162]  J. Turner,et al.  Leber's disease with symptoms resembling disseminated sclerosis , 1964, Journal of neurology, neurosurgery, and psychiatry.

[163]  L. Kurland,et al.  Multiple sclerosis in Israel. Prevalence among immigrants and native inhabitants. , 1962, Archives of neurology.

[164]  J. M. Sutherland,et al.  Observations on the prevalence of multiple sclerosis in Northern Scotland. , 1956, Brain : a journal of neurology.

[165]  D. Mcalpine,et al.  The familial incidence of disseminated sclerosis and its significance. , 1951, Brain : a journal of neurology.

[166]  Li Cc.  The geographic distribution of multiple sclerosis and its estimated prevalence in the United States. , 1950 .

[167]  F. Curtius,et al.  Multiple Sklerose und Erbanlage , 1938 .

[168]  C. Davenport.  MULTIPLE SCLEROSIS: FROM THE STANDPCINT OF GEOGRAPHIC DISTRIBUTION AND RACE , 1922 .